Tae-You Kim

C. Kang, Y. Bang, Dong-Wan Kim, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells.

Y. Bang, S. Im, D. Oh, 2010, International journal of oncology.

Prognostic Factors Affecting the Outcome of Salvage Radiotherapy for Isolated Locoregional Recurrence After Mastectomy

W. Han, D. Noh, Y. Bang, 2010, American journal of clinical oncology.

Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer

Y. S. Ju, Sheehyun Kim, Tae-You Kim, 2021, Molecular oncology.

Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation

Y. Bang, S. Im, D. Oh, 2009, Journal of gastroenterology and hepatology.

Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells.

Ju-Hee Lee, Y. Bang, Sung-Hak Kim, 2008, The international journal of biochemistry & cell biology.

A-kinase anchoring protein 12 regulates the completion of cytokinesis.

Y. Bang, Sung-Hak Kim, S. Im, 2008, Biochemical and biophysical research communications.

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib.

Young Tae Kim, Doo Hyun Chung, Tae-You Kim, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation

Y. Bang, Dong-Wan Kim, D. Heo, 2006, Clinical Cancer Research.

Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer

Tae-You Kim, Sae-Won Han, Sang-Hyun Song, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

Hepatitis B Virus Infection and B‐Cell Non‐Hodgkin's Lymphoma in a Hepatitis B Endemic Area: A Case‐control Study

Y. Bang, D. Heo, C. Kim, 2002, Japanese journal of cancer research : Gann.

TTP as a surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: meta-analysis of randomised controlled trials

S. Im, Jung-Hwan Yoon, Y. Kim, 2016, British Journal of Cancer.

Impact of Multimodality Approach for Patients with Leptomeningeal Metastases from Solid Tumors

Y. Bang, Dong-Wan Kim, D. Heo, 2014, Journal of Korean medical science.

The Impact of Primary Tumor Resection on the Survival of Patients with Stage IV Breast Cancer

W. Han, D. Noh, Sung-Won Kim, 2010 .

Therapeutic Outcome of Extranodal NK/T-Cell Lymphoma Initially Treated with Chemotherapy Result of Chemotherapy in NK/T-Cell Lymphoma

Ji Yeun Kim, Y. Bang, D. Heo, 2003, Acta oncologica.

Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors

D. Noh, H. Moon, Dong-Wan Kim, 2013, Journal of breast cancer.

Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells

Jung Weon Lee, Y. Bang, Tae-You Kim, 2008, Experimental & Molecular Medicine.

TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity.

Jung Weon Lee, Y. Bang, Mi-Sook Lee, 2004, The Biochemical journal.

Ataxia‐telangiectasia‐mutated protein expression with microsatellite instability in gastric cancer as prognostic marker

Y. Bang, S. Im, J. W. Kim, 2014, International journal of cancer.

The influence of treatment response on the impact of resection margin status after preoperative chemoradiotherapy in rectal cancer.

Seung-Yong Jeong, Y. Bang, G. Kang, 2013 .

p130 mediates TGF-β-induced cell-cycle arrest in Rb mutant HT-3 cells

Y. Bang, Tae-You Kim, H. Jong, 2002 .

Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.

Jung Weon Lee, Y. Bang, Mi-Sook Lee, 2004, International journal of oncology.

Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin.

Y. Bang, S. Im, D. Oh, 2008, International journal of oncology.

The histone deacetylace inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen

Eun Ryoung Jang, Y. Bang, G. Jeong, 2004 .

Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells

Jung Weon Lee, Y. Bang, M. Jung, 2003, Oncogene.

Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy

W. Han, D. Noh, Y. Bang, 2016, Journal of breast cancer.

Combination chemotherapy with S-1 and platinum in advanced hepatocellular carcinoma.

Y. Bang, S. Im, Jung-Hwan Yoon, 2010, Anticancer research.

Cell Adhesion Status-dependent Histone Acetylation Is Regulated through Intracellular Contractility-related Signaling Activities*

Jung Weon Lee, Y. Bang, S. Ye, 2005, Journal of Biological Chemistry.

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type.

K. Chang, Yeon-Hee Park, Y. Bang, 2005, Blood.

Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells

Tae-You Kim, Sae-Won Han, Sang-Hyun Song, 2018, Molecular oncology.

Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing

G. Kang, D. Bang, Tae-You Kim, 2020, PloS one.

Clinical Course of Neuroendocrine Tumors With Different Origins (the Pancreas, Gastrointestinal Tract, and Lung)

Y. Bang, Dong-Wan Kim, D. Heo, 2012, American journal of clinical oncology.

Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer

Jin‐Young Jang, Y. Bang, S. Im, 2020, Cancer research and treatment : official journal of Korean Cancer Association.

Phase II study of low-dose paclitaxel and cisplatin as second-line therapy in 5-fluorouracil and platinum pretreated gastric cancer

D. Heo, S. Im, Keun-Wook Lee, 2005 .

Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy

Seung-Yong Jeong, Se Hyung Kim, G. Kang, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

Docetaxel + 5-fluorouracil + cisplatin 3-day combination chemotherapy as a first-line treatment in patients with unresectable gastric cancer.

Y. Bang, Dong-Wan Kim, D. Heo, 2005, Japanese journal of clinical oncology.

Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement

Y. Bang, Dong-Wan Kim, D. Heo, 2009, Annals of Hematology.

A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells.

Jung Weon Lee, Y. Bang, M. Namba, 2003, International journal of oncology.

Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy

Y. Bang, Dong-Wan Kim, S. Im, 2010, BMC Cancer.

Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea

W. Han, D. Noh, H. Moon, 2016, Cancer research and treatment : official journal of Korean Cancer Association.

Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis

Y. Bang, S. Im, D. Oh, 2016, Cancer research and treatment : official journal of Korean Cancer Association.

Chemical Therapeutics Discovery & Preclinical Development Antitumor Activity of Saracatinib ( AZD 0530 ) , a cSrc / Abl Kinase Inhibitor , Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer

Y. Bang, P. Elvin, S. Im, 2013 .

Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer

Y. Bang, P. Elvin, S. Im, 2012, Molecular Cancer Therapeutics.

Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer.

Jin‐Young Jang, Y. Bang, S. Im, 2012, International journal of radiation oncology, biology, physics.

A multi-center, late phase II clinical trial of Genexol (paclitaxel) and cisplatin for patients with advanced gastric cancer.

Y. Bang, Dong-Wan Kim, D. Heo, 2004, Oncology reports.

Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis.

Sang Gyun Kim, Jung Weon Lee, Y. Bang, 2005, Cancer research.

Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy

Y. Bang, Dong-Wan Kim, D. Heo, 2012, Supportive Care in Cancer.

Immunohistochemical features associated with sensitivity to lapatinib-plus-capecitabine and resistance to trastuzumab in HER2-positive breast cancer.

W. Han, D. Noh, Y. Bang, 2014, Anticancer research.

Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer

Jin‐Young Jang, Y. Bang, S. Im, 2016, PloS one.

Phase II Study of Chemotherapy with ACNU Plus Cisplatin Followed by Cranial Irradiation in Patients with Newly Diagnosed Glioblastoma Multiforme

Y. Bang, Hee-Won Jung, Tae-You Kim, 2002, Journal of Neuro-Oncology.

Nomogram for Predicting Breast Conservation after Neoadjuvant Chemotherapy

Min Kyoon Kim, W. Han, D. Noh, 2014, Cancer research and treatment : official journal of Korean Cancer Association.

Standard versus longer interval of radical resection after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A 20‐year single‐center experience & propensity‐score matching

Min Jung Kim, J. Park, Seung-Yong Jeong, 2022, Journal of surgical oncology.

Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy

S. Im, Keun-Wook Lee, Jung-Hwan Yoon, 2014, Breast Cancer.

Cytotoxic effects of pemetrexed in gastric cancer cells

Y. Bang, S. Im, K. Jung, 2005, Cancer science.

Discordant human epidermal growth factor receptor 2 and hormone receptor status in primary and metastatic breast cancer and response to trastuzumab.

D. Noh, Y. Bang, S. Im, 2011, Japanese journal of clinical oncology.

Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer

Y. Bang, S. Im, S. K. Baek, 2011, BMC gastroenterology.

Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib

S. Im, Y. Kim, Jeong‐Hoon Lee, 2020, Clinical Cancer Research.

Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors

Y. Bang, D. Heo, Se-Hoon Lee, 2015, Cancer research and treatment : official journal of Korean Cancer Association.

Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer

Y. Bang, S. Im, Keun-Wook Lee, 2014, Cancer Chemotherapy and Pharmacology.

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells

Y. Bang, M. O’Connor, S. Im, 2015, Breast Cancer Research.

Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone.

Y. Bang, Dong-Wan Kim, D. Heo, 2003, Japanese journal of clinical oncology.

RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib

Y. Bang, M. O’Connor, S. Im, 2013, Molecular Cancer Therapeutics.

The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines

Y. Bang, S. Im, D. Oh, 2012, Investigational New Drugs.

Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells

Young-Kwang Yoon, Tae-You Kim, Hye-Jin Kim, 2012, Anti-cancer drugs.

Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase

Jung-Hyun Park, Sang Gyun Kim, Tae-You Kim, 2007, Journal of Molecular Medicine.

Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system

Seung-Yong Jeong, N. Cho, H. Lee, 2017, British Journal of Cancer.

Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications

Y. Bang, S. Im, C. Ock, 2016, Gastric Cancer.

Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer

Y. Bang, S. Im, C. Ock, 2015, Gastric Cancer.

EMT-mediated regulation of CXCL1/5 for resistance to anti-EGFR therapy in colorectal cancer

C. Ock, Tae-You Kim, Sae-Won Han, 2022, Oncogene.

NFATC3–PLA2G15 Fusion Transcript Identified by RNA Sequencing Promotes Tumor Invasion and Proliferation in Colorectal Cancer Cell Lines

D. Bang, Tae-You Kim, Sae-Won Han, 2018, Cancer research and treatment : official journal of Korean Cancer Association.

Phenotype-based single cell sequencing identifies diverse genetic subclones in CD133 positive cancer stem cells.

G. Kang, Sunghoon Kwon, Tae-You Kim, 2020, Biochemical and biophysical research communications.

The Signaling Network of Transforming Growth Factor β1, Protein Kinase Cδ, and Integrin Underlies the Spreading and Invasiveness of Gastric Carcinoma Cells

Jung Weon Lee, Y. Bang, Mi-Sook Lee, 2005, Molecular and Cellular Biology.

Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer

Tae-You Kim, Sae-Won Han, Sang-Hyun Song, 2015, Cancer research and treatment : official journal of Korean Cancer Association.

Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers

Y. Bang, S. Im, D. Oh, 2012, Laboratory Investigation.

Activation of WNT/β‐catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations

K. Park, Tae-You Kim, Sae-Won Han, 2018, International journal of cancer.

Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability

Tae-You Kim, Sae-Won Han, Jinah Park, 2015, Nucleic acids research.

Systemic inflammatory markers as prognostic factors in stage IIA colorectal cancer

J. Park, Seung-Yong Jeong, K. Park, 2016, Journal of surgical oncology.

Blood-Based Detection of Colorectal Cancer Using Cancer-Specific DNA Methylation Markers

N. Cho, G. Kang, Tae-You Kim, 2020, Diagnostics.

Prognostic implication of antitumor immunity measured by the neutrophil–lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer

Y. Bang, S. Im, C. Ock, 2017, Gastric Cancer.

Dynamic cohesin‐mediated chromatin architecture controls epithelial–mesenchymal plasticity in cancer

E. Yi, Tae-You Kim, Sae-Won Han, 2016, EMBO reports.

Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells

Tae-You Kim, Sung-Hak Kim, Y. Bang, 2008, Molecular Cancer Therapeutics.

Aberrant methylation of integrin α4 gene in human gastric cancer cells

Jung Weon Lee, Y. Bang, W. Kim, 2004, Oncogene.

OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells.

Y. Bang, S. Im, D. Oh, 2013, Cancer letters.

Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes

Y. Bang, J. Ku, W. Kim, 2011, Cellular Oncology.

AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity

Tae-You Kim, Noe Kyeong Kim, Jung Weon Lee, 2004, Oncogene.

17p12 deletion in breast cancer predicts resistance to neoadjuvant chemotherapy.

W. Han, D. Noh, Kap-Seok Yang, 2011, Experimental and Therapeutic Medicine.

A multivariate analysis of prognostic factors in colorectal cancer

Y. Bang, Dong-Wan Kim, D. Heo, 2003 .

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI.

Y. Bang, Dong-Wan Kim, D. Heo, 2009, Lung cancer.

Mucoepidermoid carcinoma of lung: potential target of EGFR-directed treatment.

Y. Bang, Dong-Wan Kim, D. Heo, 2008, Lung cancer.

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy‐resistant non‐small cell lung cancer

Y. Bang, Dong-Wan Kim, D. Heo, 2005, International journal of cancer.

Chasing targets for EGFR tyrosine kinase inhibitors in non-small-cell lung cancer: Asian perspectives

Y. Bang, Tae-You Kim, Sae-Won Han, 2007, Expert review of molecular diagnostics.

HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer

S. Im, Y. Jeon, I. Park, 2013, Cancer Chemotherapy and Pharmacology.

Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy

Seung-Yong Jeong, Jaemyun Lyu, G. Kang, 2019, BMC Cancer.

Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer

Taesung Park, Duhee Bang, Iksoo Huh, 2017, Cancer.

A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma

S. Im, D. Oh, Tae-You Kim, 2018, BMC Cancer.

Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer

Y. Bang, Dong-Wan Kim, D. Heo, 2007, Pharmacogenetics and genomics.

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines.

Jin Won Kim, Young-Kwang Yoon, Tae-You Kim, 2008, Cancer letters.

Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer

Tae-Yong Kim, Jin Won Kim, Woo Ho Kim, 2015, Clinical Cancer Research.

Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line

E. Yi, M. Kang, Tae-You Kim, 2013, Experimental & Molecular Medicine.

Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy

Jieun Park, Y. Bang, S. Im, 2016, Oncotarget.

Clinicopathologic Characteristics of Patients With Stage III/IV (M0) Advanced Gastric Cancer, According to HER2 Status Assessed by Immunohistochemistry and Fluorescence In Situ Hybridization

Y. Bang, S. Im, J. W. Kim, 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6

Y. Bang, S. Im, Keun-Wook Lee, 2010, Cancer science.

Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells

Ju-Hee Lee, Y. Bang, Sung-Hak Kim, 2010, Molecules and cells.

Therapeutic implication of HER2 in advanced biliary tract cancer

Y. Bang, S. Im, Ji‐Won Kim, 2016, Oncotarget.

Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells

Ju-Hee Lee, Y. Bang, Jung-Hyun Park, 2006, Molecular Cancer Therapeutics.

Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma

Y. Bang, Y. Jo, Dong-Wan Kim, 2004, Cancer.

More Accurate Prediction of Metastatic Pancreatic Cancer Patients’ Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic Activity

Y. Bang, S. Im, D. Oh, 2016, PloS one.

Histone Deacetylase Inhibitors for Cancer Therapy

Y. Bang, K. Robertson, Tae-You Kim, 2006, Epigenetics.

Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer

Seung-Yong Jeong, G. Kang, K. Park, 2018, Annals of Surgical Oncology.

RNA editing in RHOQ promotes invasion potential in colorectal cancer

Seung-Yong Jeong, Jeong-Sun Seo, Jong-Yeon Shin, 2014, The Journal of experimental medicine.

Prognostic Value of Splenic Artery Invasion in Patients Undergoing Adjuvant Chemoradiotherapy after Distal Pancreatectomy for Pancreatic Adenocarcinoma

Jin‐Young Jang, Y. Bang, S. Im, 2014, Cancer research and treatment : official journal of Korean Cancer Association.

Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer

Seung-Yong Jeong, Y. Bang, S. Im, 2013, Cancer Chemotherapy and Pharmacology.

Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer.

W. Han, D. Noh, Y. Bang, 2011, Tumori.

Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma

Y. Bang, S. Im, Ja-june Jang, 2015, BMC Cancer.

KRAS Mutation is Associated with Worse Prognosis in Stage III or High-risk Stage II Colon Cancer Patients Treated with Adjuvant FOLFOX

Seung-Yong Jeong, Y. Bang, N. Cho, 2014, Annals of Surgical Oncology.

Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer.

Y. Bang, S. Im, W. Kim, 2012, Cancer letters.

VEGF Expression is Related to Good Response and Long Progression-free Survival in Gastrointestinal Stromal Tumor Patients Treated With Sunitinib

Y. Bang, Dong-Wan Kim, D. Heo, 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

ABCB1, FCGR2A, and FCGR3A Polymorphisms in Patients with HER2-Positive Metastatic Breast Cancer Who Were Treated with First-Line Taxane plus Trastuzumab Chemotherapy

W. Han, D. Noh, Y. Bang, 2012, Oncology.

Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer.

Young-Kwang Yoon, Tae-You Kim, Hyun-Jin Nam, 2011, Cancer letters.

KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: Implication for combinatorial approach

Young-Kwang Yoon, Tae-You Kim, Y. Bang, 2010, Molecular carcinogenesis.

Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer.

Y. Bang, Sang-Il Kim, Dong-Wan Kim, 2005, Japanese journal of clinical oncology.

A Phase III Randomized Trial of Combined Chemoradiotherapy Versus Radiotherapy Alone in Locally Advanced Non–Small-Cell Lung Cancer

Y. Bang, D. Heo, Tae-You Kim, 2002, American journal of clinical oncology.

A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions

W. Han, D. Noh, Y. Bang, 2014, Cancer research and treatment : official journal of Korean Cancer Association.

Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer

W. Han, D. Noh, Sung-Won Kim, 2009, Annals of Surgical Oncology.

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

W. Han, D. Noh, Y. Bang, 2008, BMC Cancer.

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

W. Han, D. Noh, Y. Bang, 2007, BMC Cancer.

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

W. Han, D. Noh, Y. Bang, 2007, BMC cancer.

NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations

Y. Bang, S. Im, E. Park, 2011, International journal of oncology.

Class I Histone Deacetylase-Selective Novel Synthetic Inhibitors Potently Inhibit Human Tumor Proliferation

Sang Gyun Kim, Jung Weon Lee, Y. Bang, 2004, Clinical Cancer Research.

Does adjuvant radiotherapy suppress liver regeneration after partial hepatectomy?

Jin‐Young Jang, Y. Bang, S. Im, 2009, International journal of radiation oncology, biology, physics.

ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy

W. Han, D. Noh, S. Im, 2014, Cancer science.

TGF-beta1-mediated activations of c-Src and Rac1 modulate levels of cyclins and p27(Kip1) CDK inhibitor in hepatoma cells replated on fibronectin.

Jung Weon Lee, Y. Bang, Mi-Sook Lee, 2005, Biochimica et biophysica acta.

Chemical Therapeutics RAD 51 CDe fi cient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib

Y. Bang, M. O’Connor, S. Im, 2013 .

Nomogram predicting clinical outcomes in breast cancer patients treated with neoadjuvant chemotherapy

D. Noh, Y. Bang, Dong-Wan Kim, 2011, Journal of Cancer Research and Clinical Oncology.

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis

W. Han, D. Noh, Y. Bang, 2011, Breast Cancer Research.

Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor-Positive Early Breast Cancer.

W. Han, D. Noh, H. Moon, 2020, Clinical breast cancer.

Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity.

W. Han, D. Noh, Y. Bang, 2010, Japanese journal of clinical oncology.

Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric Cancer

Y. Bang, Dong-Wan Kim, D. Heo, 2007, Journal of Korean medical science.

Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer.

Y. Bang, Dong-Wan Kim, D. Heo, 2005, Japanese journal of clinical oncology.

Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy

W. Han, D. Noh, K. Kang, 2011, BMC Cancer.

ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.

Y. Bang, H. Min, Dong-Wan Kim, 2007, Lung cancer.

Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.

Sang Gyun Kim, Y. Bang, S. Im, 2008, Cancer research.

Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma

Jin‐Young Jang, Y. Bang, S. Im, 2012, Clinical and Translational Oncology.

Metastasis-Associated Protein S100A4 and p53 Predict Relapse in Curatively Resected Stage III and IV (M0) Gastric Cancer

Y. Bang, Dong-Wan Kim, D. Heo, 2008, Cancer investigation.

DNA methyltransferase 3B acts as a co-repressor of the human polycomb protein hPc2 to repress fibroblast growth factor receptor 3 transcription.

Ju-Hee Lee, Y. Bang, Sung-Hak Kim, 2008, The international journal of biochemistry & cell biology.

Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression.

Ju-Hee Lee, Y. Bang, Sung-Hak Kim, 2007, Biochemical and biophysical research communications.

Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

Y. Bang, Dong-Wan Kim, D. Heo, 2008, BMC Cancer.

Results of Breast Conserving Surgery and Subsequent Postoperative Radiotherapy for Cases of Breast Cancer

W. Han, D. Noh, Y. Bang, 2008 .

Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX

Tae-Yong Kim, Kyu Joo Park, Seung-Yong Jeong, 2015, Clinical Epigenetics.

Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer

Y. Bang, S. Im, W. Kim, 2012, Investigational New Drugs.

Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors.

J. Y. Lee, Y. Bang, Hyun-Ju Park, 2003, Journal of medicinal chemistry.

The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor α-negative breast cancer cells to tamoxifen

Eun Ryoung Jang, Soo-Jeong Lim, Tae-You Kim, 2004, Oncogene.

First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy ± radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma

Y. Bang, Dong-Wan Kim, D. Heo, 2006, Leukemia & lymphoma.

Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy

W. Han, D. Noh, Y. Bang, 2010, Cancer.

Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.

Jin‐Young Jang, Y. Bang, S. Im, 2009, International journal of radiation oncology, biology, physics.

Prognostic factors for survival in colorectal cancer patients with brain metastases undergoing whole brain radiotherapy: multicenter retrospective study

Seung-Yong Jeong, K. Park, Kyubo Kim, 2020, Scientific Reports.

Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer

Y. Bang, S. Im, D. Oh, 2016, Oncotarget.

Prognostic Value of p53 and bcl-2 Expression in Patients Treated with Breast Conservative Therapy

W. Han, D. Noh, Y. Bang, 2007, Journal of Korean medical science.

Targeted Sequencing of Cancer-Related Genes in Colorectal Cancer Using Next-Generation Sequencing

Seung-Yong Jeong, Y. Bang, Jeong-Sun Seo, 2013, PloS one.

O pen-label, Random ized C om parison of the E fficacy of Intra- venous Dolasetron M esy late and O ndansetron in the Prevention of A cute and Delayed C isplatin-induced Em esis in C ancer Patients

Y. Bang, Sang-Il Kim, Dong-Wan Kim, 2010 .

Open-label, randomized comparison of the efficacy of intravenous dolasetron mesylate and ondansetron in the prevention of acute and delayed cisplatin-induced emesis in cancer patients.

Y. Bang, Sang-Il Kim, Dong-Wan Kim, 2004, Cancer research and treatment : official journal of Korean Cancer Association.

The synergism between Belotecan and cisplatin in gastric cancer.

Y. Bang, S. Im, Jung-Hyun Park, 2006, Cancer research and treatment : official journal of Korean Cancer Association.

Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment

W. Han, D. Noh, Y. Bang, 2011, Journal of Neuro-Oncology.

Proteomic analysis reveals that CD147/EMMPRIN confers chemoresistance in cancer stem cell‐like cells

E. Yi, Y. Kwon, M. Kang, 2013, Proteomics.

Heterodimerization of Glycosylated Insulin-Like Growth Factor-1 Receptors and Insulin Receptors in Cancer Cells Sensitive to Anti-IGF1R Antibody

K. Kang, Y. Bang, E. Yi, 2012, PloS one.

Correlation of HER2, p95HER2 and HER3 Expression and Treatment Outcome of Lapatinib plus Capecitabine in her2-Positive Metastatic Breast Cancer

Y. Bang, S. Im, Weidong Huang, 2012, PloS one.

Doxorubicin‐based chemotherapy for diffuse large B‐cell lymphoma in elderly patients

Y. Bang, Dong-Wan Kim, Keun-Wook Lee, 2003, Cancer.

The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy

Y. Bang, S. Im, D. Oh, 2015, Cancer research and treatment : official journal of Korean Cancer Association.

A combination of HER‐2 status and the St. Gallen classification provides useful information on prognosis in lymph node‐negative breast carcinoma

W. Han, D. Noh, Y. Bang, 2004, Cancer.

Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells

Y. Bang, S. Im, D. Oh, 2009, Molecular Cancer Therapeutics.

CPR or DNR? End-of-life decision in Korean cancer patients: a single center’s experience

Y. Bang, Dong-Wan Kim, D. Heo, 2006, Supportive Care in Cancer.

Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy

Y. Bang, S. Y. Park, S. Im, 2009, Journal of Korean medical science.

Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin

Duhee Bang, Kyu Joo Park, Seung-Yong Jeong, 2019, Clinical Cancer Research.

High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer

Y. Bang, Y. Im, S. Im, 2010, Breast Cancer Research and Treatment.

Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses

W. Han, D. Noh, H. Ryu, 2016, BMC Cancer.

Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer

D. Noh, W. Moon, H. Moon, 2013, Annals of Surgical Oncology.

CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy

Y. Bang, S. Im, J. Rhee, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

Asymmetrical barcode adapter-assisted recovery of duplicate reads and error correction strategy to detect rare mutations in circulating tumor DNA

Byungjin Hwang, D. Bang, Tae-You Kim, 2017, Scientific Reports.

Predict Relapse in Curatively Resected Stage III and IV ( M 0 ) Gastric Cancer

Y. Bang, Dong-Wan Kim, D. Heo, 2008 .

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index

Y. Bang, S. Im, D. Oh, 2015, PloS one.

Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy

Y. Bang, S. Im, D. Oh, 2017, Oncotarget.

Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer

Seung-Yong Jeong, Y. Bang, N. Cho, 2016, British Journal of Cancer.

Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer

Seung-Yong Jeong, Y. Bang, N. Cho, 2013, International journal of cancer.

The impact of body mass index dynamics on survival of patients with advanced pancreatic cancer receiving chemotherapy.

Y. Bang, S. Im, D. Oh, 2013, Journal of pain and symptom management.

Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer

Y. Bang, S. Im, C. Ock, 2016, Gastric Cancer.

Associations and prognostic implications of Eastern Cooperative Oncology Group performance status and tumoral LINE-1 methylation status in stage III colon cancer patients

N. Cho, G. Kang, Tae-You Kim, 2016, Clinical Epigenetics.

RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase.

Ju-Hee Lee, Y. Bang, S. Im, 2010, Cancer letters.

Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study

Y. Bang, Dong-Wan Kim, D. Heo, 2008, BMC Cancer.

Role of Adjuvant Chemoradiotherapy for Duodenal Cancer: A Single Center Experience

Jin‐Young Jang, Y. Bang, S. Im, 2012, American journal of clinical oncology.

High Fluorodeoxyglucose Uptake on Positron Emission Tomography in Patients with Advanced Non–Small Cell Lung Cancer on Platinum-Based Combination Chemotherapy

Y. Bang, Dong-Wan Kim, D. Heo, 2006, Clinical Cancer Research.

Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response

W. Han, D. Noh, S. Im, 2013, Journal of breast cancer.

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer

Woo Kyung Moon, Wonshik Han, Jung Min Chang, 2012, Breast Cancer Research.

Reduced Dose Intensity FOLFOX-4 as First Line Palliative Chemotherapy in Elderly Patients with Advanced Colorectal Cancer

Y. Bang, Dong-Wan Kim, D. Heo, 2005, Journal of Korean medical science.

Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: Which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study

Jin‐Young Jang, Y. Bang, S. Im, 2009, BMC Cancer.

Body Mass Index Is Not Associated with Treatment Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Korean Data

D. Noh, Y. Bang, Dong-Wan Kim, 2012, Journal of breast cancer.

Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients.

Y. Bang, Dong-Wan Kim, D. Heo, 2006, Lung cancer.

Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy

D. Noh, Y. Bang, W. Moon, 2009, Breast Cancer Research and Treatment.

Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer

Y. Bang, S. Im, J. W. Kim, 2013, Cancer Chemotherapy and Pharmacology.

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less

D. Noh, Sung-Won Kim, Y. Bang, 2010, BMC Cancer.

Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting

Y. Bang, S. Im, K. Lim, 2011, Cancer Chemotherapy and Pharmacology.

Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer

Y. Bang, S. Im, Y. Yoon, 2012, Cancer Chemotherapy and Pharmacology.

A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker.

Y. Bang, Dong-Wan Kim, D. Heo, 2008, Molecular medicine reports.

Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2

Young-Kwang Yoon, Tae-You Kim, Ju-Hee Lee, 2009, PloS one.

Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells.

Sang Gyun Kim, Y. Bang, S. Im, 2006, Anticancer research.

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells

Y. Bang, M. O’Connor, S. Im, 2015, Breast Cancer Research.

The lack of CD34 expression in gastrointestinal stromal tumors is related to cystic degeneration following imatinib use.

Y. Bang, Dong-Wan Kim, D. Heo, 2012, Japanese journal of clinical oncology.

Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study

Y. Bang, Tae-You Kim, S. Im, 2015, Cancer research and treatment : official journal of Korean Cancer Association.

Total lesion glycolysis (TLG) as an imaging biomarker in metastatic colorectal cancer patients treated with regorafenib

Seung-Yong Jeong, G. Kang, K. Park, 2017, European Journal of Nuclear Medicine and Molecular Imaging.

Adjuvant Chemoradiotherapy After Curative Resection for Extrahepatic Bile Duct Cancer: A Long-term Single Center Experience

Jin‐Young Jang, Y. Bang, S. Im, 2012, American journal of clinical oncology.

Is duodenal invasion a relevant prognosticator in patients undergoing adjuvant chemoradiotherapy for distal common bile duct cancer?

Jin‐Young Jang, Y. Bang, S. Im, 2010, International journal of radiation oncology, biology, physics.

Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study

Y. Bang, S. Im, Dong-Yeop Shin, 2011, Cancer Chemotherapy and Pharmacology.

Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial

Sooyoung Cho, Tae-You Kim, A. Shin, 2020, Scientific Reports.

A Phase I study of cis‐malonato[(4R,5R)‐4,5‐bis(aminomethyl)‐1,3‐dioxolane] platinum(II) in patients with advanced malignancies

Y. Bang, D. Heo, Tae-You Kim, 2001, Cancer.

Results of breast‐conserving therapy for multifocal or multicentric breast cancers

W. Han, D. Noh, Y. Bang, 2009 .

Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX

N. Cho, H. Lee, G. Kang, 2021, Scientific Reports.

Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors

Y. Bang, Keun-Wook Lee, I. Jang, 2015, Cancer research and treatment : official journal of Korean Cancer Association.

The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma

W. Han, D. Noh, H. Moon, 2011, Breast Cancer Research and Treatment.

Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy

Y. Bang, S. Im, D. Oh, 2016, Nutrition and cancer.

Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients

J. Park, Seung-Yong Jeong, Y. Bang, 2015, BMC Cancer.

Aberrant methylation of integrin alpha4 gene in human gastric cancer cells.

Jung Weon Lee, Y. Bang, W. Kim, 2004, Oncogene.

Prognostic factors for survival in colorectal cancer patients with brain metastases undergoing whole brain radiotherapy: multicenter retrospective study

Seung-Yong Jeong, K. Park, Kyubo Kim, 2020, Scientific Reports.

Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer

Jin‐Young Jang, Y. Bang, S. Im, 2016, American journal of clinical oncology.

Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications.

Y. Bang, S. Im, D. Oh, 2015, The oncologist.

Korean Cancer Patients’ Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate

Y. Bang, Dong-Wan Kim, D. Heo, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma

S. Im, D. Oh, Tae-You Kim, 2018, BMC Cancer.

The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen.

Y. Bang, S. Im, J. W. Kim, 2012, Anticancer research.

Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy

S. Im, Y. Jeon, I. Park, 2013, Cancer Chemotherapy and Pharmacology.

Nomogram prediction of survival and recurrence in patients with extrahepatic bile duct cancer undergoing curative resection followed by adjuvant chemoradiation therapy.

Jin‐Young Jang, Y. Bang, S. Im, 2013, International journal of radiation oncology, biology, physics.

Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX

Seung-Yong Jeong, Y. Bang, N. Cho, 2015, Clinical Epigenetics.

Comparison of concurrent chemoradiotherapy and chemotherapy alone for locally advanced pancreatic cancer.

Y. Bang, S. Im, Kyubo Kim, 2014 .

Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer.

Y. Bang, D. Heo, D. Y. Kim, 2003, Lung cancer.

The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer.

Y. Bang, S. Im, C. Ock, 2015, American journal of cancer research.

CD24 expression predicts distant metastasis in extrahepatic bile duct cancer.

Jin‐Young Jang, Y. Bang, H. Min, 2013, World journal of gastroenterology.

IMbrave150: A randomized phase III study of 1L atezolizumab plus bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinoma.

P. Galle, M. Ducreux, A. Zhu, 2018 .

Reply to ‘Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system”

Seung-Yong Jeong, N. Cho, H. Lee, 2018, British Journal of Cancer.

Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer.

Y. Bang, Dong-Wan Kim, D. Heo, 2006, Japanese journal of clinical oncology.

Antibiotic use during the last days of life in cancer patients.

Y. Bang, J. Kim, Dong-Wan Kim, 2006, European journal of cancer care.

Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX

Y. Bang, Se Hyung Kim, S. Im, 2016, Cancer research and treatment : official journal of Korean Cancer Association.

Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives

Y. Bang, Dong-Wan Kim, D. Heo, 2008, British Journal of Cancer.

Phosphorylated Akt Expression as a Favorable Prognostic Factor for Patients Undergoing Curative Resection and Adjuvant Chemoradiotherapy for Proximal Extrahepatic Bile Duct Cancer

Jin‐Young Jang, Y. Bang, H. Min, 2017, American journal of clinical oncology.

Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer

Y. Bang, S. Im, K. Lim, 2012, Oncology.

The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen.

Eun Ryoung Jang, Y. Bang, L. J. Schelven, 2004, Oncogene.

The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer.

Y. Bang, Dong-Wan Kim, D. Heo, 2010, Lung cancer.

KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: Implication for combinatorial approach

Y. Bang, S. Im, D. Oh, 2010, Molecular carcinogenesis.

Src as a Therapeutic Target in Biliary Tract Cancer

Y. Bang, S. Im, Ji‐Won Kim, 2016, Molecular Cancer Therapeutics.

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6

Y. Bang, S. Im, Keun-Wook Lee, 2010, Cancer science.

Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy

Seung-Yong Jeong, Y. Bang, N. Cho, 2013, British Journal of Cancer.

Testican-1-mediated epithelial–mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer

S. Im, Tae-You Kim, T. Kim, 2014, Oncogene.

W. Han, D. Noh, Y. Bang, 2007, BMC Cancer.

OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells.

Y. Bang, S. Im, D. Oh, 2013, Cancer letters.

Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?

Jin‐Young Jang, Y. Bang, S. Im, 2016, Clinical and Translational Oncology.

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

W. Han, D. Noh, Y. Bang, 2008, BMC Cancer.

Does adjuvant radiotherapy suppress liver regeneration after partial hepatectomy?

Jin‐Young Jang, Y. Bang, S. Im, 2009, International journal of radiation oncology, biology, physics.

A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer.

Y. Bang, Y. Kim, J. Kim, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer

Y. Bang, S. Im, J. W. Kim, 2015, Clinical Cancer Research.

Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone.

Y. Bang, D. Heo, S. Im, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Reply to ‘Comment on ‘Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system”

Seung-Yong Jeong, N. Cho, H. Lee, 2018, British Journal of Cancer.

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

Y. Bang, S. Im, Tae-You Kim, 2009, British Journal of Cancer.

Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer

Y. Bang, P. Elvin, S. Im, 2012, Molecular Cancer Therapeutics.

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines.

Y. Bang, S. Im, J. W. Kim, 2008, Cancer letters.

Postoperative chemoradiotherapy for gallbladder cancer

Y. Bang, D. Oh, Tae-You Kim, 2012, Strahlentherapie und Onkologie.

BIOMARKERS, GENOMICS, PROTEOMICS, AND GENE REGULATION Identification of Long-Range Epigenetic Silencing on Chromosome 15q25 and Its Clinical Implication in Gastric Cancer

G. Kang, Tae-You Kim, Sae-Won Han, 2015 .

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

Y. Bang, S. Im, D. Oh, 2009, British Journal of Cancer.

Activity of the anti-IGF-1R antibody dalotuzumab (MK-0646) in KRAS-mutant colorectal cancer: Preclinical and clinical data

M. Ayers, G. Naumov, J. Tabernero, 2012 .

Abstract 5189: RNA editing in rhoq promotes invasion potential in colorectal cancer

Jeong-Sun Seo, K. Park, Tae-You Kim, 2014 .

Antitumor activity of NVP‐AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins

Ju-Hee Lee, Y. Bang, S. Im, 2011, Cancer science.

The synergism between Belotecan and cisplatin in gastric cancer.

Y. Bang, S. Im, Jung-Hyun Park, 2006, Cancer research and treatment : official journal of Korean Cancer Association.

Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy

Y. Bang, Dong-Wan Kim, S. Im, 2010, BMC Cancer.

Dynamic cohesin‐mediated chromatin architecture controls epithelial–mesenchymal plasticity in cancer

E. Yi, Tae-You Kim, Sae-Won Han, 2016, EMBO reports.

The impact of diabetes mellitus and metformin on survival of patients with advanced pancreatic cancer receiving chemotherapy.

Y. Bang, S. Im, D. Oh, 2013 .

Transforming growth factor-beta 1 induces apoptosis through Fas ligand-independent activation of the Fas death pathway in human gastric SNU-620 carcinoma cells.

Y. Bang, Tae-You Kim, H. Jong, 2004, Molecular biology of the cell.